Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0360-3016(99)00066-8PMID 10348291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Classification of Malignant Tumors

  1998cited by this paper
• Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma.

  1997cited by this paper
• Prognostic Factors in Metastatic Malignant Melanoma

  1997cited by this paper
• Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.

  1995cited by this paper
• The role of adjuvant therapy in melanoma management

  1995cited by this paper
• The national cancer data base. Report on melanoma

  1994cited by this paper
• Postoperative radiotherapy for cutaneous melanoma of the head and neck region.

  1994cited by this paper
• Prognostic factors in metastatic melanoma

  1993cited by this paper
• Long‐term follow‐up for brain metastases treated by percutaneous stereotactic single high‐dose irradiation

  1993cited by this paper
• Cerebral metastases from malignant melanoma.

  1992cited by this paper
• Disposition of cerebral metastases from malignant melanoma: implications for radiosurgery.

  1991cited by this paper
• [Role and methods of radiotherapy in the treatment of malignant melanoma].

  1991cited by this paper
• Survival with regional and distant metastases from cutaneous malignant melanoma.

  1991cited by this paper
• Role and methods of radiotherapy in the treatment of malignant melanoma

  1991cited by this paper
• Fraction size in external beam radiation therapy in the treatment of melanoma.

  1991cited by this paper
• A randomized trial of surgery in the treatment of single metastases to the brain.

  1990cited by this paper
• Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results.

  1990cited by this paper
• The role of radiation therapy following resection of single brain metastasis from melanoma

  1990cited by this paper
• Local tumor control following single dose irradiation of human melanoma xenografts: relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse.

  1989cited by this paper
• Clinical radiobiology of malignant melanoma.

  1989cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• Central nervous system involvement in malignant melanoma.

  1988cited by this paper
• Central nervous system lnvolvement in malignant melanoma

  1988cited by this paper
• Radiotherapy in the management of cutaneous melanoma: effect of time, dose, and fractionation.

  1988cited by this paper
• Analysis of dose fractionation in the palliation of metastases from malignant melanoma

  1988cited by this paper
• Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma

  1988cited by this paper
• Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression.

  1988cited by this paper
• Prognostic Factors in Advanced Metastatic and Recurrent Melanoma Treated with DTIC

  1987cited by this paper
• Early metastatic patterns and survival in malignant melanoma

  1987cited by this paper
• Malignant melanoma: analysis of dose fractionation in radiation therapy.

  1987cited by this paper
• Metastatic distribution in malignant melanoma. A 30-year autopsy study.

  1987cited by this paper
• Prognostic index for malignant melanoma

  1987cited by this paper
• Palliative radiotherapy for metastatic malignant melanoma

  1987cited by this paper
• Malignant Melanoma: Prognostic Factors

  1987cited by this paper
• Radiation biology of malignant melanoma.

  1986cited by this paper
• Some factors of importance in the radiation treatment of malignant melanoma.

  1986cited by this paper
• Brain metastases from malignant melanoma: conventional vs. high-dose-per-fraction radiotherapy.

  1986cited by this paper
• The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study.

  1986cited by this paper
• Metastatic melanoma in brain. Rapid treatment or large dose fractions

  1985cited by this paper
• Intracranial metastases from melanoma clinical features and treatment by accelerated fractionation

  1985cited by this paper
• The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

  1985cited by this paper
• Prognosis of patients with pathologic stage II cutaneous malignant melanoma.

  1985cited by this paper
• A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.

  1985cited by this paper
• Clinical-biologic patterns of metastatic melanoma and their effect on treatment.

  1985cited by this paper
• Malignant melanoma prognostic factors 6: distant metastases and length of survival.

  1984cited by this paper
• Prognosis of skin melanoma with regional node metastases (stage II)

  1984cited by this paper
• Prognostic parameters in recurrent malignant melanoma

  1983cited by this paper
• A new isoeffect curve for change in dose per fraction.

  1983cited by this paper
• A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).

  1983cited by this paper
• Low- and high-risk malignant melanoma--I. Evaluation of clinical and histological prognosticators in 585 cases.

  1983cited by this paper
• 0‐7‐21 radiotherapy in nodular melanoma

  1983cited by this paper
• Low- and high-risk malignant melanoma--II. Multivariate analyses for a prognostic classification.

  1983cited by this paper
• Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.

  1982cited by this paper
• The radioresponsiveness of melanoma.

  1982cited by this paper
• Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes

  1982cited by this paper
• The female superiority in survival in clinical stage. II. Cutaneous malignant melanoma

  1982cited by this paper
• Metastases in malignant melanoma.

  1982cited by this paper
• Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

  1982cited by this paper
• A Multifactorial Analysis of Melanoma: III. Prognostic Factors in Melanoma Patients with Lymph Node Metastases (Stage II)

  1981cited by this paper
• The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system.

  1981cited by this paper
• Radiotherapy for malignant melanoma: a re-appraisal.

  1981cited by this paper
• The radiosensitivity of malignant melanomas part I: experimental studies.

  1981cited by this paper
• The radiosensitivity of malignant melanomas part II: clinical studies.

  1981cited by this paper
• Radiotherapy in the management of malignant melanoma.

  1981cited by this paper
• The results of different fractionation schemes in the palliative irradiation of metastatic melanoma.

  1981cited by this paper
• MALIGNANT MELANOMA: AN ANDROGEN-DEPENDENT TUMOUR?

  1980cited by this paper
• Radiotherapy of intracerebral metastatic malignant melanoma.

  1980cited by this paper
• Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.

  1979cited by this paper
• Present role and future prospects for radiotherapy in the management of malignant melanomas.

  1979cited by this paper
• Radiation therapy of malignant melanomas: An evaluation of clinically used fractionation schemes

  1979cited by this paper
• Optimal fractionation for the radiotherapy of tumour cells possessing wide-shouldered survival curves.

  1979cited by this paper
• The relationship between total dose, number of fractions and fractions size in the response of malignant melanoma in patients.

  1978cited by this paper
• Endocrine influences on survival from malignant melanoma

  1978cited by this paper
• Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized, prospective study

  1978cited by this paper
• Prognostic index for malignant melanoma.

  1978cited by this paper
• Radiation therapy of malignant melanoma. Experience with high individual treatment doses

  1976cited by this paper
• Letter: Pain in gastric ulcer.

  1974cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• The radiosensitivity of melanoma cells in culture.

  1971cited by this paper
• The radiation response of human malignant melanoma cells grown in vitro.

  1971cited by this paper
• Value of radiation therapy for distant metastases from malignant melanoma

  1963cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• The Roentgen Treatment of Carcinoma of the Breast: A Review of 601 Cases treated at the Radium Centre for Jutland during the Years 1924 to 1936

  1944cited by this paper
• The Radiosensitivity of Malignant Melanomata

  1939cited by this paper

• In-transit melanoma metastases: Evaluation and Management for the Dermatologist.

  2025cites this paper
• Impact of facility volume on overall survival among patients with skin cancer undergoing palliative treatment

  2025cites this paper
• Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of Systemic Therapy, Shortcomings and Future Directions.

  2025cites this paper
• A Review of Melanoma Subtypes: Genetic and Treatment Considerations

  2024cites this paper
• Recent advancements in the diagnosis and treatment of acral melanoma

  2024cites this paper
• Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

  2023influential citation
• Strahlentherapie des Melanoms

  2023cites this paper
• Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis

  2023cites this paper
• Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial

  2022cites this paper
• Management of In-Transit Metastases

  2022cites this paper
• Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases

  2022cites this paper
• Surgery for liver metastases from primary melanoma: a systematic review and meta-analysis

  2022cites this paper
• Impact of electrochemotherapy in metastatic cutaneous melanoma: a contemporary systematic review and meta-analysis

  2021cites this paper
• Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review

  2021cites this paper
• Practical Management of Melanoma

  2021cites this paper
• Local and regional therapy for primary and locally recurrent melanoma.

  2021cites this paper
• Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007–2018

  2021cites this paper
• Retrospective analysis of the efficacy and safety of cabazitaxel treatment in castration-resistant prostate cancer after docetaxel failure

  2020cites this paper
• The PICO Model for Effective Learning of Holistic and Comprehensive Care in an Atypical Case of Metastatic Melanoma

  2020cites this paper
• Locoregional management of in-transit metastasis in melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.

  2020cites this paper
• The Prognosis and Natural History of In-Transit Melanoma Metastases at a High-Volume Centre

  2019cites this paper
• Efficacy of combined radiotherapy and anti‐programmed death 1 therapy in acral and mucosal melanoma

  2019cites this paper
• The role of radiotherapy in melanoma

  2019cites this paper
• Treatment of Metastatic Melanoma

  2018cites this paper
• Radiotherapie des kutanen malignen Melanoms

  2018cites this paper
• Management of in‐transit melanoma metastases: a review

  2018cites this paper
• Management of Melanoma Locoregional Recurrence

  2018cites this paper
• Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma

  2018cites this paper
• Do you know your guidelines? Diagnosis and management of cutaneous head and neck melanoma

  2018cites this paper
• Palliative radiotherapy for skin malignancies.

  2017cites this paper
• Results of a phase II, open‐label, non‐comparative study of intralesional PV‐10 followed by radiotherapy for the treatment of in‐transit or metastatic melanoma

  2017cites this paper
• 18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

  2017cites this paper
• S3‐Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms – Update 2015/2016, Kurzversion 2.0

  2017cites this paper
• Skin: The Case for Altered Fractionation in the Treatment of Both Malignant and Benign Conditions

  2017cites this paper
• Chapter 15 Surgery and the Staging of Melanoma

  2017cites this paper
• Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG).

  2016cites this paper
• Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models

  2016cites this paper
• The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.

  2016cites this paper
• Palliative radiotherapy for Japanese patients with malignant melanoma: a single-institution experience

  2016cites this paper
• Dermal Radiomics: a new approach for computer-aided melanoma screening system

  2016cites this paper
• Treatment of malignant melanoma with nivolumab and vemurafenib combined with hypofractionated radiation therapy

  2016cites this paper
• Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities.

  2016cites this paper
• Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series

  2016cites this paper
• Radiation Therapy in the Management of Malignant Melanoma.

  2015cites this paper
• Isolated limb infusion: Efficacy, toxicity and an evolution in the management of in-transit melanoma

  2015cites this paper
• Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice

  2015cites this paper
• Surgical palliation for malignant disease requiring locoregional control.

  2015cites this paper
• The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options

  2015cites this paper
• Radiation therapy for advanced and metastatic melanoma

  2014cites this paper
• Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review

  2014cites this paper
• Analysis of clinical, dermoscopic and histopathological features of primary melanomas of patients with metastatic disease – a retrospective study at the Department of Dermatology, Medical University of Graz, 2000–2010

  2014cites this paper
• Locoregional therapies in melanoma.

  2014cites this paper
• Increased skin and mucosal toxicity in the combination of vemurafenib with radiation therapy

  2014cites this paper
• Immunomodulation of malignant melanoma by contact sensitizing agents

  2014cites this paper
• Metastatic malignant melanoma: computed tomography-guided 125I seed implantation treatment

  2014cites this paper
• Treatment of Primary Tumor and Locoregional Disease

  2013cites this paper
• Elderly man with rapidly enlarging axillary mass.

  2013cites this paper
• Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

  2013cites this paper
• A Case of Rectal Amelanotic Melanoma

  2013cites this paper
• Malignes Melanom S3‐Leitlinie “Diagnostik, Therapie und Nachsorge des Melanoms”

  2013cites this paper
• The role of radiotherapy in the overall treatment of melanoma.

  2013cites this paper
• S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version

  2013cites this paper
• Das Wichtigste für die Praxis

  2013cites this paper
• Die neue S3-Leitlinie „Melanom“

  2013cites this paper
• Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma.

  2013cites this paper
• Surgery and the Staging of Melanoma

  2013cites this paper
• Current Treatment of Locoregional Recurrence of Melanoma

  2013cites this paper
• Treatment of Distant and Irresectable Metastatic Disease

  2013cites this paper
• GRM1, A POTENTIAL TARGET FOR HUMAN MELANOMA

  2013cites this paper
• Radiation Therapy and Skin Cancer

  2012cites this paper
• MelanomaPractice Guidelines in Oncology

  2012cites this paper
• Radiation therapy for cutaneous melanoma.

  2012cites this paper
• Surgical treatment of sacral metastases: indications and results.

  2012cites this paper
• Electrochemotherapy for disseminated superficial metastases from malignant melanoma

  2012cites this paper
• Expression von SLC-Transportern in Melanomzelllinien und Charakterisierung von MATE1 und OCT1 in ihrer Funktion als Zytostatikatransporter

  2011influential citation
• Cutaneous Metastases from Malignant Melanoma: Clinical Features and New Therapeutic Perspectives

  2011cites this paper
• In-transit melanoma: an individualized approach.

  2011influential citation
• Is Radiotherapy An Effective Treatment Option for Recurrent Metastatic Malignant Melanoma? a Case Report of Short-Course, Large-Fraction Radiation and a Literature Review

  2011cites this paper
• Urgent access to a specialty care melanoma clinic is associated with a higher rate of melanoma detection.

  2011cites this paper
• Melanoma: the radiotherapeutic point of view; review of the current literature.

  2011cites this paper
• The role of radiation therapy in the management of cutaneous melanoma.

  2011cites this paper
• Stellenwert der Sentinel-Lymphonodektomie in der Therapie des malignen Melanoms. Eine 854 Patienten umfassende retrospektive Studie.

  2011cites this paper
• Successful treatment of melanoma metastatic to the left atrium using external beam radiation therapy.

  2010influential citation
• 79. Radiotherapy and Reactions to Ionizing Radiation

  2010cites this paper
• Role of radiotherapy in melanoma management

  2010cites this paper
• Role of radiation therapy in cutaneous melanoma.

  2010cites this paper
• Melanoma metastatic to multiple visceral organs: further considerations.

  2010cites this paper
• Strahlentherapie des kutanen Melanoms

  2010cites this paper
• Genetic biomarkers as prognostic and predictive factors in metastatic malignant melanoma

  2010cites this paper
• Malignant melanoma: a retrospective series from a regional cancer center in India.

  2009cites this paper
• Standards und Trends bei der Behandlung des malignen Melanoms

  2009cites this paper
• Malignes Melanom

  2009cites this paper
• Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma

  2009cites this paper
• Metastatic malignant melanoma of the conjunctiva: a case report

  2009cites this paper
• Surgery and radiotherapy in the treatment of cutaneous melanoma

  2009cites this paper
• Current status of hyperthermic limb perfusion for in-transit melanoma

  2008cites this paper
• Cutaneous Malignant Melanoma

  2008cites this paper
• Therapy for unresectable recurrent and in-transit extremity melanoma.

  2008cites this paper
• Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy

  2008cites this paper
• Radiotherapy and Reactions to Ionizing Radiation

  2008cites this paper